EC Healthcare, an investment holding company, engages in the provision of medical and healthcare services in Hong Kong, Macau, and the People's Republic of China. The company operates through three segments: Medical, Aesthetic Medical and Beauty and Wellness, and Others. It provides quasi-medical, beauty and wellness, medical imaging, medical surgery, aesthetic medical beauty, aesthetic medical, dental, hair treatment, vaccine, chiropractic, psychological, and orthopedics services. It also offers administrative, management, laboratory testing, performance marketing, marketing, and travel agency services; sells beauty and skincare products; operates in healthcare machines and property investment holding businesses; and provides multi-channel networking and related services, and veterinary services. The company offers products and services primarily under private-label brands, such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. EC Healthcare was founded in 2005 and is headquartered in Mong Kok, Hong Kong.
EC Healthcare Dividend Announcement
• EC Healthcare announced a semi annually dividend of HK$0.01 per ordinary share which will be made payable on 2025-01-24. Ex dividend date: 2024-12-30
• EC Healthcare annual dividend for 2024 was HK$0.01
• EC Healthcare annual dividend for 2023 was HK$0.05
• EC Healthcare's trailing twelve-month (TTM) dividend yield is 0.68%
• EC Healthcare's payout ratio for the trailing twelve months (TTM) is -293.92%
• EC Healthcare's dividend growth over the last five years (2018-2023) was -24.77% year
EC Healthcare Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-30 | HK$0.01 | semi annually | 2025-01-24 |
2023-12-28 | HK$0.01 | semi annually | 2024-01-19 |
2023-09-04 | HK$0.04 | semi annually | 2023-09-18 |
2022-12-28 | HK$0.06 | semi annually | 2023-01-20 |
2022-09-05 | HK$0.04 | semi annually | 2022-09-20 |
2021-12-30 | HK$0.10 | semi annually | 2022-01-21 |
2021-09-03 | HK$0.13 | semi annually | 2021-09-20 |
2021-01-04 | HK$0.03 | semi annually | 2021-01-21 |
2020-09-02 | HK$0.08 | semi annually | 2020-09-11 |
2020-01-02 | HK$0.15 | semi annually | 2020-01-21 |
2019-08-27 | HK$0.14 | semi annually | 2019-09-06 |
2019-08-22 | HK$0.14 | semi annually | |
2018-12-13 | HK$0.10 | semi annually | 2018-12-28 |
2018-08-22 | HK$0.10 | semi annually | 2018-09-06 |
2017-12-13 | HK$0.09 | semi annually | 2018-01-19 |
2017-08-24 | HK$0.08 | semi annually | 2017-09-12 |
2016-12-09 | HK$0.05 | semi annually | 2016-12-29 |
2016-09-26 | HK$0.02 | semi annually | 2016-10-12 |
EC Healthcare Dividend per year
EC Healthcare Dividend growth
EC Healthcare Dividend Yield
EC Healthcare current trailing twelve-month (TTM) dividend yield is 0.68%. Interested in purchasing EC Healthcare stock? Use our calculator to estimate your expected dividend yield:
EC Healthcare Financial Ratios
EC Healthcare Dividend FAQ
Other factors to consider when evaluating EC Healthcare as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy EC Healthcare stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: EC Healthcare's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, EC Healthcare publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, EC Healthcare distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from EC Healthcare are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: EC Healthcare sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, EC Healthcare distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: EC Healthcare declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of EC Healthcare's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review EC Healthcare's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.